As we read the headlines about the Senate Hearings and Corporate Integrity Agreement it is clear that Commercially Supported CME is at a crossroads.
Now is the time for industry professionals to join together to explore and discuss the current state of Medical Education. One opportunity is to learn and share with the faculty of this crucial event on September 24th and 25th in Philadelphia. Many of the major issues impacting the work you do will be on the agenda, including:
Pre Conference Workshop:
What do people do in the sessions you fund: what, exactly, does it mean “to teach” and “to learn?”
Hank Slotnick PhD, Professor Emeritus, UNIVERSITY OF NORTH DAKOTA
Judith Ribble, PhD, CCMEP,
Executive Director, National Commission for Certification of CME Professionals, Inc., NC-CME
Public Disclosure & Reporting Of Financial Support – Next Steps
Beth Brillinger, Sr. Manager, Medical Education Grants, Astra Zeneca
Karen Small, Sr. Manager, Medical Education Grants, Astra Zeneca
Catalyst For Change: Finding Growth Opportunities In The New Environment
Theresa M. Vera, PhD, Manager, Medical Education, Medical & Scientific Affairs, Takeda Pharmaceuticals North America Inc.
Group Discussion
The Future Of Commercially Supported CME
Led by Brian McGowan, Senior Director, IME, WYETH
Cephalon Group Presentation:
Grant Request Review: The Good, the Bad and the Ugly!
Cephalon Presenters:
Karen Roy, MSc, Director Medical Education
Sue McGuinness, PhD, Manager, Medical Education
Bhaval Shah Bell, PhD, Associate Director, Medical Education
Moderator:
Barbara A Fuchs, CCMEP, CPHQ, Consultant, EPIQ Services, LLC
Understanding The Pharma Cme Planning Process
Laura Muttini, RPh, MBA, CCMEP, Associate Director, Pharmaceutical Products Division, Grant Management Department, Abbott
Grant Requests: Through The Lenses Of The Corporate Sponsor
Kimberly Boothe, PharmD, MHA, BCPS, Deputy Director, Medical Education & Investigator Sponsored Studies, Bayer Healthcare
PhRMA Code – Interpretations and Implications
Barbara R. Giddings, RN, MHA, CHC, Commercial Compliance, Biogen Idec
Metrics and Rate Card Benchmarking For Budgets
Germaine Aprill, PharmD, Director, Independent Medical Education, ASTELLAS PHARMA US, INC.
Current Outcome Levels: Are Commercial Supporters Getting What They Need?
Jason M. Singer, PharmD, CCMEP, Senior Grant Associate, Lilly Grant Office, Lilly USA
Making A Case For The Value Of CME: Time To Move Beyond The Reactive To The Pro-Active
Michael J. Paradiso, Director, Novartis Office of Grants & Education, Medical Information & Communications, NOVARTIS
For more information or to register online at: www.exlpharma.com/grants